HRT
HRT Patches
How HRT patches work, how they compare to other delivery methods, and why the choice of HRT format should follow clinical assessment rather than precede it.
Many women search for HRT patches specifically because they want to understand how different forms of hormone replacement therapy compare in practical terms. Patches are one of several ways to deliver oestrogen — alongside gels, sprays and oral tablets — and each has its own clinical profile, advantages and considerations. The difficulty is that comparison without context can be misleading. The right form of HRT depends on the symptoms being treated, the medical history, whether progestogen is also needed, and individual factors that are best assessed in a proper menopause consultation.
If you have not yet had a broader menopause assessment, that is the more useful starting point than choosing a delivery method. See menopause and HRT for the full clinical pathway.
ON THIS PAGE
How HRT patches work
Transdermal patches deliver oestrogen through the skin into the bloodstream, bypassing the liver and gastrointestinal tract. This route of delivery avoids the first-pass hepatic metabolism that occurs with oral HRT, which has clinical implications for certain risk profiles. Patches are typically changed once or twice per week depending on the brand. They deliver a steady level of oestrogen, which some women find produces more consistent symptom control than oral preparations where levels can fluctuate between doses.
When patches may be clinically preferred
Transdermal oestrogen — whether delivered by patch or gel — may be clinically preferred for women with a BMI over 30, a history of venous thromboembolism, migraine with aura, hypertension, gallbladder disease, or elevated triglycerides. Current evidence suggests that transdermal preparations carry a lower risk of VTE and stroke compared with oral oestrogen, which is why many prescribers now favour this route for a wider range of patients. However, transdermal delivery is not universally necessary. For women without specific risk factors, oral HRT remains a reasonable option.
Comparison
How patches compare to gels and tablets
Patches offer convenience — applied once or twice weekly with minimal daily routine. Gels are applied daily and allow finer dose titration. Oral tablets are familiar and straightforward but involve hepatic metabolism. Sprays are a newer option with a similar pharmacological profile to gels. Each has practical trade-offs: patches can occasionally cause skin irritation at the application site; gels require drying time and careful hand-washing; tablets are the simplest to use but carry marginally higher VTE risk for certain patients.
The clinical decision should be guided by individual risk factors, symptom profile, lifestyle, and personal preference. There is no universally best delivery method — only the one that is most appropriate for each patient’s situation.
Same-day appointments available. Book online or call 020 7736 7557.
Why the correct starting point is assessment, not product selection
Choosing between patches, gel and tablets is a prescribing decision that depends on clinical assessment. It requires consideration of whether HRT is appropriate, which hormones are needed (oestrogen alone or combined with progestogen), what dose is likely to be effective, and whether the patient’s risk profile favours one route over another. A menopause consultation at Basuto covers all of these considerations and leads to a personalised treatment plan rather than a generic recommendation.
Ongoing care
Review and adjustment over time
HRT is not a fixed prescription. Doses may need adjusting, delivery methods may need changing, and symptom response should be reviewed periodically. Some patients start with patches and later switch to gel for easier dose titration. Others move from oral to transdermal as risk factors evolve. The important thing is that treatment remains responsive to the current clinical picture rather than continuing on autopilot.
At Basuto, menopause care includes structured follow-up so that prescriptions continue to match the clinical picture over time. Where side effects develop, these can be discussed and managed at a follow-up consultation.
Frequently asked questions
Are HRT patches better than tablets?
Not universally. Patches bypass the liver and may carry a lower risk of VTE and stroke, which makes them preferable for women with certain risk factors. But oral tablets remain a reasonable option for many women. The choice should be based on clinical assessment rather than a general assumption that one format is always superior.
Can I switch from tablets to patches?
Yes. Switching between HRT preparations is common and can be discussed during a menopause review. Reasons for switching include side effects, a change in risk factors, or simply personal preference for a different delivery method. Your GP can advise on timing and dosage adjustments.
Do I need blood tests before starting HRT?
Not always. Perimenopause is usually diagnosed clinically from symptoms and history. But hormone blood tests or thyroid tests may be useful where the picture is unclear, where symptoms could have another cause, or where baseline health screening would inform the treatment decision.
FURTHER READING